Skip to main content

Table 1 Total costs on the pregnancy outcomes

From: Screening for autoimmune thyroid disorders after spontaneous abortion is cost-saving and it improves the subsequent pregnancy rate

   Physiological delivery Premature delivery SC SpA Secondary infertility
Discount factor   1.000 1.000 1.000 1.000 0.971
Number of women Treated 24 4 10 23 3
Untreated 10 2 4 9 8
Controls 52 8 24 20 16
Total unit costs (€) Treated 389 402 493 287 1,516
Untreated 346 359 450 244 1,473
Controls 282 295 386 180 1,409
Total Costs (€) Treated 9,334 1,608 4,929 6,607 4,547
Untreated 3,805 718 1,799 2,442 11,782
Controls 14,386 2,362 9,265 3,428 22,543
  1. Discount factors were chosen on the relationship of the average time in the group of women after SpA (time from the reference SpA to the termination of subsequent pregnancy). There was no different in average time between the subgroups Treated, Untreated and Controls. The costs included the costs of screening for thyroid disease, regular endocrine controls, LT4 treatment and costs of pregnancy outcomes. Costs are calculated as a weighted average. Discount rate 3%, time horizon 4 years prospective, payer’s perspective. SpA, spontaneous abortion; SC, section cesarean.